Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intra-Tympanic Methylprednisolone + PRP for SNHL and Tinnitus
NCT06025097Phase 1Completed
- Start
- Sep 2023
- Primary completion
- Sep 2023
- Modality
- Adipose-derived MSCs, Bone Marrow MSCs
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of platelet-rich plasma in sensorineural hearing loss (SNHL) and tinnitus. Primary endpoints: Improvement in Hearing and Improvement in Tinnitus. Started Sep 2023; status: completed.
02
Drugs
platelet-rich plasma
03
Conditions
sensorineural hearing loss (SNHL)tinnitus
Beyond the preview
Go deeper on NCT06025097.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06025097.